Molecule Details
| InChIKey | GIMMLOSBIAMYRJ-AREVGRJGSA-N |
|---|---|
| Compound Name | [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[4-[[(4-sulfamoylbenzoyl)amino]methyl]triazol-1-yl]oxyoxan-2-yl]methyl acetate |
| Canonical SMILES | CC(=O)OC[C@H]1O[C@@H](On2cc(CNC(=O)c3ccc(S(N)(=O)=O)cc3)nn2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.59 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile